{"id":"https://openalex.org/W1991664599","doi":"https://doi.org/10.1002/ijc.2910490405","title":"The systemic complement activation caused by interleukin\u20102/lymphokine\u2010activated killer\u2010cell therapy of cancer causes minimal systemic neutrophil activation","display_name":"The systemic complement activation caused by interleukin\u20102/lymphokine\u2010activated killer\u2010cell therapy of cancer causes minimal systemic neutrophil activation","publication_year":1991,"publication_date":"1991-10-21","ids":{"openalex":"https://openalex.org/W1991664599","doi":"https://doi.org/10.1002/ijc.2910490405","mag":"1991664599","pmid":"https://pubmed.ncbi.nlm.nih.gov/1917149"},"language":"en","primary_location":{"id":"doi:10.1002/ijc.2910490405","doi":"https://doi.org/10.1002/ijc.2910490405","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.2910490405","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109969533","display_name":"Francis D. Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Francis D. Moore","raw_affiliation_strings":["Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115","Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041688417","display_name":"Deric D. Schoof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deric D. Schoof","raw_affiliation_strings":["Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110328103","display_name":"Mary Lofy Rodrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Rodrick","raw_affiliation_strings":["Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032371242","display_name":"Timothy J. Eberlein","orcid":"https://orcid.org/0009-0008-7076-2357","observed_orcids":["https://orcid.org/0009-0008-7076-2357"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Eberlein","raw_affiliation_strings":["Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109969533"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":{"value":5030,"currency":"USD","value_usd":5030},"apc_paid":null,"fwci":0.4994,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.60588565,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"49","issue":"4","first_page":"504","last_page":"508"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8809999823570251},{"id":"https://openalex.org/keywords/lymphokine-activated-killer-cells","display_name":"lymphokine-activated killer cells","score":0.9919999837875366},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/c3a-desarg","display_name":"C3a desArg","score":0.8149999976158142},{"id":"https://openalex.org/keywords/neutrophil-chemotaxis","display_name":"neutrophil chemotaxis","score":0.9079999923706055},{"id":"https://openalex.org/keywords/fmlp","display_name":"fMLP","score":0.7649999856948853},{"id":"https://openalex.org/keywords/complement-receptor-1","display_name":"complement receptor 1","score":0.9670000076293945},{"id":"https://openalex.org/keywords/complement-receptor-type-3","display_name":"complement receptor type 3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cancer-immunotherapy-toxicity","display_name":"cancer immunotherapy toxicity","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2779499704","wikidata":"https://www.wikidata.org/wiki/Q5008266","display_name":"C5a receptor","level":4,"score":0.7117301225662231},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.6890760064125061},{"id":"https://openalex.org/C54166955","wikidata":"https://www.wikidata.org/wiki/Q658145","display_name":"Chemotaxis","level":3,"score":0.6245131492614746},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5841678380966187},{"id":"https://openalex.org/C49382859","wikidata":"https://www.wikidata.org/wiki/Q286498","display_name":"Lymphokine","level":3,"score":0.5084392428398132},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48836204409599304},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.47909122705459595},{"id":"https://openalex.org/C71318922","wikidata":"https://www.wikidata.org/wiki/Q426181","display_name":"Complement component 5","level":4,"score":0.4259379506111145},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38936376571655273},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.38311558961868286},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24595773220062256}],"mesh":[{"descriptor_ui":"D002634","descriptor_name":"Chemotaxis, Leukocyte","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003165","descriptor_name":"Complement System Proteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003167","descriptor_name":"Complement Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009240","descriptor_name":"N-Formylmethionine Leucyl-Phenylalanine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D015979","descriptor_name":"Killer Cells, Lymphokine-Activated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ijc.2910490405","doi":"https://doi.org/10.1002/ijc.2910490405","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.2910490405","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:1917149","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1917149","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G120585504","display_name":null,"funder_award_id":"GM 5633","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G3100623080","display_name":null,"funder_award_id":"AI 24139","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4422925753","display_name":"ALTERNATIVE METHOD OF ADOPTIVE IMMUNOTHERAPY","funder_award_id":"R01CA045484","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G492780927","display_name":null,"funder_award_id":"CA45484","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W98951888","https://openalex.org/W230712602","https://openalex.org/W1528317551","https://openalex.org/W1819732475","https://openalex.org/W1872737808","https://openalex.org/W1910438132","https://openalex.org/W1964032970","https://openalex.org/W1977096306","https://openalex.org/W1983221620","https://openalex.org/W2002121879","https://openalex.org/W2007332219","https://openalex.org/W2044027546","https://openalex.org/W2077702220","https://openalex.org/W2126843316","https://openalex.org/W2337093996","https://openalex.org/W2396602000","https://openalex.org/W2407317077","https://openalex.org/W2410402031","https://openalex.org/W2463397481","https://openalex.org/W2795740701","https://openalex.org/W2796598183","https://openalex.org/W4247189630","https://openalex.org/W4300627763"],"related_works":["https://openalex.org/W29729594","https://openalex.org/W2085406326","https://openalex.org/W2267582171","https://openalex.org/W2417417665","https://openalex.org/W2179970611","https://openalex.org/W1977667843","https://openalex.org/W7063706530","https://openalex.org/W2414109292","https://openalex.org/W1964032970","https://openalex.org/W1978420045"],"abstract_inverted_index":{"Twenty-three":[0],"cancer":[1],"patients":[2],"undergoing":[3],"therapy":[4,162],"with":[5,37],"interleukin-2":[6],"and":[7,18,71,81,103,125],"lymphokine-activated":[8],"killer":[9],"cells":[10],"were":[11,54],"studied":[12],"for":[13,123],"evidence":[14,32],"of":[15,26,33,40,48,51,60,65,87,92,98,135,147,155,160,169],"complement":[16,35,99,104,136],"activation":[17,21,137,168],"systemic":[19],"neutrophil":[20,95,143],"occurring":[22],"during":[23],"the":[24,45,58,73,90,114,145,148,158],"course":[25],"therapy.":[27,49,61],"Patient":[28],"plasma":[29],"samples":[30],"demonstrated":[31],"marked":[34],"activation,":[36,144],"3-fold":[38],"elevations":[39],"C3a":[41],"desArg":[42,53],"concentrations":[43],"by":[44,57,89,167],"8th":[46],"day":[47],"Concentrations":[50],"C4a":[52],"also":[55],"elevated":[56],"end":[59,91],"In":[62,153],"vitro":[63],"chemotaxis":[64],"patients'":[66],"neutrophils":[67,150],"both":[68],"to":[69,72,85,113],"C5a":[70],"synthetic":[74],"peptide":[75],"chemotaxin,":[76],"FMLP,":[77],"was":[78,126,151],"initially":[79],"normal":[80,88],"then":[82],"fell":[83],"progressively":[84],"60%":[86],"treatment.":[93],"Mean":[94],"cell-surface":[96],"expression":[97],"receptor":[100,105],"Type":[101,106],"1":[102],"3":[107],"increased":[108],"in":[109,116],"inverse":[110],"temporal":[111],"relationship":[112],"deficit":[115],"chemotaxis,":[117],"but":[118],"showed":[119],"no":[120],"consistent":[121],"pattern":[122],"individuals":[124],"only":[127],"doubled":[128],"at":[129],"maximum.":[130],"Thus,":[131],"despite":[132],"a":[133],"degree":[134],"which":[138],"should":[139],"have":[140],"produced":[141],"pronounced":[142],"response":[146],"circulating":[149,170],"diminished.":[152],"view":[154],"this":[156,161],"discrepancy,":[157],"toxicity":[159],"may":[163],"not":[164],"be":[165],"mediated":[166],"neutrophils.":[171]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}